Remdesivir can save more lives where ICUs are overwhelmed
Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning to overwhelm intensive care units (ICUs).
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: African Health | Boston University | COVID-19 | Hospitals | Intensive Care | International Medicine & Public Health | Pharmaceuticals | South Africa Health | Study | USA Health